Empire Genomics (Buffalo, New York, USA) has announced that it has chosen Funakoshi as a distributor of its product portfolio for the Japanese market.
Empire Genomics (Buffalo, New York, USA) has announced that it has chosen Funakoshi as a distributor of its product portfolio for the Japanese market. The deal highlights Empire's international expansion and growth in the region.
Anthony Johnson, President and CEO of Empire Genomics, commented, “We are excited to have such a proven and expert partner in Funakoshi to service our Japanese customers and offer access to our broad genomic product and service portfolio. I am confident this relationship will provide customers with the excellent support and high quality service our customers have come to expect.”
Dr Ryoya Funakoshi, President and CEO of Funakoshi Company, Ltd., said, “We are delighted with Empire Genomics’ agreement. Empire Genomics perfectly complements our portfolio range of high-quality products and services. The Empire Genomics portfolio provides Funakoshi Company the opportunity to meet high demands for basic bioscience research and also for the pharmaceutical research in Japan.”
For more information please visit ref="http://www.empiregenomics.com">www.empiregenomics.com
Inside the Laboratory: The Gionfriddo Group at the University of Buffalo
March 28th 2024In this edition of “Inside the Laboratory,” Emanuela Gionfriddo, PhD, an associate professor of chemistry at the University at Buffalo, discusses her group’s current research endeavors, including using solid-phase microextraction (SPME) coupled to liquid chromatography (LC) and gas chromatography (GC) to further understand the chemical relationship between environmental exposure and disease and elucidate micropollutants fate in the environment and biological systems.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.
Sustainable Green Solvents in Microextraction: A Review of Recent Advancements
March 27th 2024Conventional sample preparation can be time- and resource-consuming, and a green analytical methodology can be a game-changer for scientists, in addition to facilitating selective and sensitive separations.